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CRM1 exports proteins that carry a short leucine-rich peptide signal, the nuclear export signal (NES), from the nucleus.
Regular NESs must have low affinity for CRM1 to function optimally. We previously generated artificial NESs with higher
affinities for CRM1, termed supraphysiological NESs. Here we identify a supraphysiological NES in an endogenous
protein, the NS2 protein of parvovirus Minute Virus of Mice (MVM). NS2 interacts with CRM1 without the requirement
of RanGTP, whereas addition of RanGTP renders the complex highly stable. Mutation of a single hydrophobic residue
that inactivates regular NESs lowers the affinity of the NS2 NES for CRM1 from supraphysiological to regular. Mutant
MVM harboring this regular NES is compromised in viral nuclear export and productivity. In virus-infected mouse
fibroblasts we observe colocalization of NS2, CRM1 and mature virions, which is dependent on the supraphysiological
NS2 NES. We conclude that supraphysiological NESs exist in nature and that the supraphysiological NS2 NES has a
critical role in active nuclear export of mature MVM particles before cell lysis.
INTRODUCTION
CRM1 is a general purpose nuclear export receptor, which
transports a wide range of proteins and RNAs out of the
nucleus. Many cargoes that associate with CRM1 do so via a
short leucine-rich nuclear export signal (NES), either directly
or indirectly (reviewed in Fornerod and Ohno, 2002). The
direction of nuclear export is imposed by RanGTP. This is
because NESs can only bind CRM1 stably in the presence of
RanGTP, which is present in high concentration in the nu-
cleus and not in the cytoplasm. Nuclear export complexes
dissociate in the cytoplasm through the combined action of
RanGAP and RanBP1 (reviewed in Fornerod and Ohno,
2002). The translocation through the NPC is dependent on
CRM1/nucleoporin interactions and in its simplest mode
has little or no directionality (Becskei and Mattaj, 2003).
Indeed, export can be reversed if NES/CRM1 association is
allowed to occur in the cytoplasm (Nachury and Weis, 1999).
Therefore, a key factor for the export system to work effi-
ciently is that the affinity of the NES for CRM1 in the absence
of RanGTP should be low enough to prevent CRM1/cargo
complexes from forming in the cytoplasm.
Recently, we generated a series of NES variants through
reiterative screening of a phage library that display 100 fold
greater affinity for CRM1 than regular NESs (Engelsma et al.,
2004). We termed these artificially generated NES variants
supraphysiological NESs or supraNESs. These NESs bind
CRM1 stably in the cytoplasm in the absence of RanGTP,
thereby functioning as competitive inhibitors of CRM1 func-
tion. Another distinct feature of these supraNESs is their prom-
inent localization at the nuclear envelope (NE), largely depen-
dent on nucleoporin Nup358. This characteristic NE
localization likely reveals a dissociation step in nuclear export
in vivo (Engelsma et al., 2004). So far, supraNESs have not been
encountered in proteins evolved by natural selection.
Minute Virus of Mice (MVM) is an autonomous mouse
parvovirus with a 5-kb single-stranded DNA genome consist-
ing of two overlapping transcriptional units. Early transcrip-
tion drives the expression of two nonstructural proteins NS1
and NS2. At later time points the structural proteins VP1 and
VP2 are expressed. In the nucleus, VP proteins form an icosa-
hedral capsid with a diameter close to 25 nm that encapsulates
the viral DNA. Parvoviruses assemble in the nucleus and
have evolved mechanisms for nuclear export independent of
cell lysis, conceivably in order to gain systemic infection
(discussed in Maroto et al., 2004). Parvovirus particles are
small enough to pass through the NPC, which has been
thought to have a maximal inner diameter of39 nm (Pante
and Kann, 2002). However, only DNA-filled viral capsids
are efficiently exported from the nucleus. This requires the
N-terminus of VP2 (2Nt), which is exposed from the viral
capsid when an ssDNA molecule is present within (Maroto
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et al., 2004). MVM virions have two different ways of nuclear
exit. In transformed human fibroblastst, the capsids can exit
in an NS2 and CRM1 independent way (Maroto et al., 2004).
In mouse fibroblasts, export of MVM virions is inhibited by
the CRM1 inhibitor leptomycin B (LMB; Maroto et al., 2004),
indicating involvement of CRM1. Nuclear export of MVM in
these cells is also dependent on NS2, which is the only
known CRM1 substrate encoded by MVM (Bodendorf et al.,
1999; Eichwald et al., 2002). Consistently, viruses with a
mutated NS2 NES fail to be exported to the cytoplasm of
mouse fibroblasts and display strongly reduced fitness in
culture (Eichwald et al., 2002). Thus, NS2-dependent nuclear
export of mature viral particles appears, at least in their
natural host, to be CRM1-mediated and a critical step in
MVM infection cycle (see below).
Interestingly, CRM1 has been shown to relocalize to the
cytoplasm in cells infected with an immunosuppressive
strain of MVM (MVMi; Lopez-Bueno et al., 2004). In partic-
ular, cytoplasmic sequestration of CRM1 was prominent in
viruses selected in severe combined immunodeficiency
(SCID) mice that carried point mutations close to the NS2
NES and showed enhanced CRM1 binding in cell lysates
(Lopez-Bueno et al., 2004). These findings led us to investi-
gate whether NS2 may in fact contain a supraNES. We first
analyzed the localization of NS2 in more detail and found
that it was present not only in the cytoplasm, but accumu-
lated at the nuclear periphery as well. Study of the behavior
and biochemical characteristics of the NS2 NES indeed iden-
tified NS2 as a supraNES-bearing protein. We find that the
NS2 supraNES is critical for MVM nuclear export in mouse
fibroblasts. Collectively, our findings demonstrate that su-
praNESs are observed in nature and have been coopted by
the MVM virus to promote its life cycle and pathogenicity.
MATERIALS AND METHODS
Antibodies
Antibodies were diluted in PBS/1% milk and used as follows; rabbit anti-
serum against NS2 (Faisst et al., 1995) was used 1:200, rabbit anti-serum
against CRM1 (Fornerod et al., 1997b) 1:250, mAb raised against an epitope of
the MVM capsid surface (B7a; Lopez-Bueno et al., 2003) 1:200, rabbit anti-
serum 2Nt raised against the N-terminus of VP2 (Maroto et al., 2004)1:200,
guinea-pig anti-serum Nup358 (Walther et al., 2002) 1:100, and rabbit anti-
body NFB p65 (sc-372) 1:500.
Plasmids and Plasmid Construction
pdBMVp and pdBMV-NES22 (Eichwald et al., 2002), Nmd3-GFP (Thomas and
Kutay, 2003), and pS and pSNup358 (Bernad et al., 2004) were described
previously. To construct pX-NS2P, a NcoI/BamHI fragment containing the
MVMp NS2P cDNA (nt 260 to nt 2692 minus nt 515-1989 and nt 2281–2376)
was excised from pTM1-NS2P (kindly provided by P. Tattersall, Yale Univer-
sity, New Haven, CT) and was first subcloned into pGBT9 (Clontech, Palo
Alto, CA), in which an NcoI site was previously inserted in the multiple
cloning site using the following EcoRI linker: 5 AATTCACCATGGTTAAC 3
and 5 AATTGTTAACCATGGTG, to generate pGBT9-NS2P and then into
pALTER-1 (Promega, Madison, WI) as a EcoRI/BamHI fragment to generate
pALTER-NS2P. The NS2P cDNA-containing EcoRI/HindIII fragment was
further excised from pALTER-NS2P and inserted into the EcoRI/HindIII site
of pX (a vector kindly provided by G. Superti-Furga, EMBL, Heidelberg,
Germany). To construct pX-NS2_NES8, the so-called “NES6” and “NES8”
primers with the respective sequences: 5-AGTGGATGAAGCGACCAAA-
AAGGCCGGCACGCTC-3 and 5-CCAAAAAGGCCGGCACGGCCACCGCT-
CACGACACCGAAAAG-3 were subsequently introduced into pALTER-NS2P
using the Altered SitesR in vitro Mutagenesis System (Promega) according to the
manufacturer’s instructions. The resulting pALTER-NS2P_NES6 and pALTER-
NS2P_NES8 were further sequenced to check for the presence of the mutations
within the NS2 NES site. The EcoRI/HindIII fragment, containing the NS2P
mutated cDNA, was further excised from pALTER-NS2-NES8 and inserted into
the EcoRI/HindIII site of pX-NS2P. To construct green fluorescent protein (GFP)-
NS2 and pRSET-NS2, a BamHI/HindIII fragment excised from pX-NS2 (NS2p
isoform, obtained from Peter Tattersall,Yale University, New Haven, CT) was
inserted into the BamHI/HindIII sites of pEGFP-C1 or pRSET-A. To construct
GFP-NS2AAAA and pRSET-NS2AAAA, pX-NS2-NES8 was digested with XmnI
and the insert containing the mutated NES was inserted in XmnI-digested
GFP-NS2 and pRSET-NS2. For GFP-NS2-NES, GFP-NS2-NESL89A, GFP-NS2-
NESI91A, GFP-NS2-NESL89A/I91A, and GFP-PKIL44A, oligos (only Fw are
shown) containing HindIII and BamHI overhangs (not shown) with the follow-
ing respective sequences were annealed: 5-TCGGTGGATGAAATGACCA-
AAAAGTTCGGCACGCTCACCATTCACGACG-3, 5-TCGGTGGATGAAAT-
GACCAAAAAGTTCGGCACGGCCACCATTCACGACG-3, 5-TCGGTGGAT-
GAAATGACCAAAAAGTTCGGCACGCTCACCGCTCACGACG-3, 5-TCGG-
TGGATGAAATGACCAAAAAGTTCGGCACGGCCACCGCTCACGACG-3,
5-AGCTTACTTGGCCCTGAAGCTGGCCGGCGCCGATATCG-3. These oli-
gos were subcloned into HindIII/BamHI digested pEGFP-C1 (Clontech). For
pRev-S4-GFP, 5-TTGGGGCTGTTGATTTGTTGGCTCGTCTGTTTTCTGCTCT-
GAGTGTTAGTGGGGCCGCA-3 oligos with a BamHI and PinAI overhangs
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Figure 1. NS2 localizes to the NE via Nup358. (A) A9 cells transfected with MVM expression plasmid pdBMVp for 24 h and stained with
anti-NS2 and anti-capsid antibodies. (B) HeLa cells expressing untagged NS2 were stained after 24 h with anti-NS2 antibodies. MCF7 cells
were transfected for 24 h with (C) NS2-GFP, (D) NS2AAAA–GFP, or (E) NS2-NES-GFP. White arrows indicate NE localization. (F and G) MCF7
cells were transfected with pSuper-Nup358 and Nup358 levels were determined after 72 h using Nup358 antibodies. (F) An example of
GFP-NS2 localization in control cells or cells depleted of Nup358. (G) Boxplots showing relative amounts of NE-located GFP-tagged protein
in control cells or Nup358 knockdown cells were determined by dividing the NE pixel intensity by the cytoplasmic pixel intensity, measured
at three sites of the NE. Medians are indicated in red. p values were calculated using Mann-Whitney tests.
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were subcloned into pRev(1.4)-GFP (Henderson and Eleftheriou, 2000). The
eGFP-NES insert containing the protein kinase A inhibitor NES was amplified by
PCR from pBSSK (Roth et al., 2003) using the forward primer containing a HindIII
site 5-CGATAAGCTTGATGGTGAGCAAGGGCGAGGAG-3 and a reverse
primer, 5-AGCTGGAGCTCCACCGCGGTG-3, and subcloned into pCDNA3
(Stratagene, La Jolla, CA) by digestion with HindIII and NotI.
Recombinant Protein Expression and Purification
Expression of GFP3-S1, Rna1p, CRM1, and GFP-PKI was described previously
(Engelsma et al., 2004). Native His6-tagged NS2 and NSAAAA (10% purity;
used for RanGAP assays) were purified using Ni-NTA agarose (Qiagen,
Chatsworth. CA). Highly pure His6-tagged NS2 protein (95% purity, used
for Biocore assays) was isolated from inclusion bodies in 8 M urea purified in
Ni-NTA and refolded by stepwise dialysis to 20 mM HEPES, pH 7.9, 200 mM
NaCl, 1 mM DTT, and 8.7% glycerol. Refolded protein was subsequently
eluted as a single peak below 30 kDa from a HiLoad S75 16/60 gel filtration
column (GE Healthcare, Waukesha, WI). Eluted protein was concentrated
using Centricon concentrator (10-kDa cutoff) to 0.8 mg/ml.
CRM1 RanGAP Assays
GAP assay were performed as described previously (Askjaer et al., 1999). The
following sequences of peptides were used: NS2-NES, CVDEMTKKFGTLTIHDTEK;
NS2-NES22, CVDEMTKKFGTQSIHDTEK; and REVNES, CLQLPPLERLTL.
Cell Culture and Transfections
MCF7, low passage HeLa (ATCC, Manassas, VA; CCL-2), L929, and A9 cells
were cultured in DMEM, containing 10% fetal bovine serum (Invitrogen,
Carlsbad, CA) and antibiotics. MCF7, HeLa, and L929 cells were transfected
using Fugene 6 (Roche, Indianapolis, IN), and A9 cells were transfected with
Lipofectamine (Invitrogen). Images were taken using Leica TCS-NT2, SP2,
and AOBS confocal microscopes (Deerfield, IL) and analyzed using Image J
software (http://rsb.info.nih.gov/ij/). pSuper constructs were transfected for
72 h. Only cells with reduced Nup358 levels were scored for the presence of
GFP protein at the NE. 20–40 cells per conditions were scored. LMB, 50 nM,
was used when indicated. GFP-NS2-NES22 transfection was recorded live
using a temperature-controlled chamber build onto the Leica AOBS micro-
scope.
MVM Infections and Plaque Assay
Infections and virus production was performed as described previously (Eich-
wald et al., 2002). Plaque assays were performed as described previously
(Lopez-Bueno et al., 2004).
Immunofluorescence Stainings and Image Analysis
Stainings were done as described previously (Bernad et al., 2004). Pre-extrac-
tion was performed with 0.5% Triton X-100 in PBS for 1 min on ice, after
which the coverslips were fixed in 3.7% formalin in PBS for 10. Images were
acquired on a Leica AOBS confocal microscope. Image analysis was done in
Image J, a program, developed at the U.S. National Institutes of Health. For
nucleocytoplasmic distributions, log2 nuclear to cytoplasmic ratios were cal-
culated. Log transformation was applied to obtain equal representation of all
ratios (log ratios showed normal distributions, whereas ratios usually did
not). Colocalization analysis was done using the Colocalization Test plugin
developed by Wayne Rasband (Research Services Branch, National Institute
of Mental Health, Bethesda, MD) and Tony Collins (Wright Cell Imaging
Facility, University Health Network, Toronto, Canada), available at http://
www.uhnresearch.ca/facilities/wcif. Pearson’s correlation coefficients (R) of
intranuclear regions were calculated as well as those of randomized images.
Correlation coefficients were squared to obtain a linear approximation to
explained variance. Statistical analyses were done in R (www.r-project.org).
Surface Plasmon Resonance Spectroscopy
Surface plasmon resonance (SPR) spectroscopy was performed at 25°C on a
Biacore T100 (GE Healthcare). CRM1 and NS2 were immobilized on a CM5
chip with amine coupling in 10 mM sodium acetate at pH 5.5 (CRM1) or
pH4.5 (NS2). Approximately 17,000 response units (RUs) of CRM1 and 1800
response units (RUs) of NS2 were immobilized on the chip. For binding
measurements, NS2 (18 M), CRM1 (0.64 M), or PKI NES peptide (50 M)
in the presence or absence of 30 M (CRM1 chip) or 50 M (NS2 chip)
RanGTP were streamed over the chip in 20 mM HEPES-KOH pH 7.9, 200 mM
sodium chloride, 8.7% glycerol at 0.03 ml/min. Simultaneously, an empty
flow cell was used as reference. Biacore T100 evaluation software was used for
analysis of the data.
RESULTS
Parvovirus NS2 Is Localized at Nucleoporin Nup358
The interaction between CRM1 and NS2 is directly mediated
by an NES in NS2 (Askjaer et al., 1999; Miller and Pintel, 2002;
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Figure 2. NS2 relocalizes CRM1 from the nucleus to the cytoplasm
(A) MCF7 cells expressing NS2-GFP (left and right) or NS2-NES-
GFP (middle). When indicated, cells were treated with LMB for 3 h.
Cells were stained with anti-CRM1 antibodies. (B) Boxplot summa-
rizing quantifications (n  36 each) of CRM1 subcellular distribu-
tion exemplified in A. Medians are indicated in red. (C) Distribution
of nuclear (left) and cytoplasmic (right) CRM1 intensities, showing
both an NS2-dependent nuclear decrease and a cytoplasmic in-
crease, which is LMB-sensitive. Densities were calculated using a
bandwidth of 8. p values according to Mann-Whitney tests (D) A9
cells mock-infected () or infected with MVMp (wt) or MVMp-
NES22 (NES22) for 48 h and stained for both capsid and CRM1.
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Ohshima et al., 1999). Recently, expression of NS2 was shown
to increase the cytoplasmic fraction of CRM1 (Lopez-Bueno
et al., 2004), resembling the effect of supraNES proteins (En-
gelsma et al., 2004). As supraNES-bearing proteins are expected
to reside prominently at the NE, we first studied the localiza-
tion of NS2. Immunostaining of NS2 in A9 cells expressing the
MVM genome showed that NS2 localized in part to the NE
(Figure 1A, specificity of the antibody for this method is shown
in Supplementary Figure 1). We also observed this NE local-
ization in cells expressing untagged or GFP-tagged NS2 (Fig-
ure 1, B and C). GFP-NS2 accumulated in the nucleus of cells
expressing higher NS2 levels, possibly because supraNESs in-
hibit their own export at higher concentrations (Figure 1C,
right). To address whether the NE localization was carried out
by the NES of NS2, consensus hydrophobic residues were
mutated into alanines (NS2AAAA). Expression of this construct
resulted in a complete loss of nuclear rim staining (Figure 1D).
In addition, the isolated NS2 NES peptide fused to GFP
(NS2NES-GFP) was localized at the NE (Figure 1E). Therefore,
the NS2 NES is required and sufficient for NS2 NE localization.
Because supraNES/CRM1 complexes arrest at Nup358
(Engelsma et al., 2004), we tested whether NS2 also localized
to this cytoplasmic nucleoporin. On knockdown in MCF7
cells of Nup358 levels by expression of shRNAs targeting
Nup358 (Engelsma et al., 2004) GFP-NS2 was depleted from
the nuclear rim (Figure 1, F and G). NS2NES-GFP and the
synthetic GFP-S4 supraNES, a variant of the previously de-
scribed S1 supraNES (Engelsma et al., 2004), were similarly
depleted from the nuclear rim, indicating that Nup358 me-
diates nuclear rim localization of NS2 (Figure 1G).
NS2 Relocalizes CRM1 to the Cytoplasm and Interferes
with the CRM1-Export Pathway
CRM1 is relocalized to the cytoplasm in response to the
expression of supraNES variants (Engelsma et al., 2004). As
human cells infected with MVMi similarly relocalize CRM1
to the cytoplasm (Lopez-Bueno et al., 2004), we wondered
whether CRM1 relocalization was mediated by the NS2
NES. Indeed, NS2-GFP expression depleted CRM1 from the
nucleus and relocalized it to the cytoplasm (Figure 2A,
quantified in B and C). Expression of the isolated NS2-NES
fused to GFP resulted in a similar CRM1 relocalization (Fig-
ure 2A), indicating that it is NES mediated. On addition of
LMB, NS2 accumulates in the nucleus, and CRM1 relocal-
ization was largely abolished (Figure 2, A–C). In cells in-
fected with MVM, CRM1 was also increased in the cyto-
plasm (Figure 2D). Furthermore, MVM carrying a
previously described NS2 NES mutant, NES22, which car-
ries point mutations in the NS2 NES (Eichwald et al., 2002),
did not relocalize CRM1 to the cytoplasm (Figure 2D).
Previously, we have shown that the expression of a su-
praNES leads to inhibition of its own export by compromis-
ing CRM1 function. We therefore investigated if NS2 could
also block CRM1-mediated export. This was tested for the
NFB protein, whose cytoplasmic localization is mediated
by CRM1 (Tam et al., 2000). As shown in Figure 3A, expres-
sion of GFP-NS2, but not the NES-dead variant GFP-
NS2AAAA, led to the accumulation of endogenous NFB in
the nucleus. A quantification of this experiment is presented
in Figure 3B. Significant nuclear accumulation of NFB only
occurred in cells expressing relatively high amounts of NS2
(Supplementary Figure 2). We also tested whether export of
an exogenously expressed protein was hampered. We there-
fore studied the localization of the 60S preribosomal export
adaptor Nmd3 (Ho et al., 2000; Thomas and Kutay, 2003).
Export of GFP-Nmd3 was also inhibited in cells expressing
NS2, but not in cells expressing NS2AAAA (Figure 3C).
Some viruses inhibit nuclear transport pathways of the
host cell in order to enhance export of their own cargoes
(Fontoura et al., 2005). The previously described MVM
NES22 mutant is an MVM strain that contains a mutated
supraNES. This viral strain is severely deficient in viral
propagation. We investigated whether the viral propagation
of this mutant virus could be rescued by expressing a su-
praNES exogenously, leading to CRM1 inhibition. A9 cells
were transfected with pdBMVp or pdBMV-NES22 viral
DNA in combination with NS2NES-GFP or GFP. Viral par-
ticles present in the supernatant were harvested 48 h after
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Figure 3. NS2 interferes with the CRM1 export
pathway. (A) NS2 inhibits the cytoplasmic localiza-
tion of NFB. L929 cells were transfected with GFP-
NS2 or GFP-NS2AAAA and stained for NFB. (B)
Boxplots summarizing quantifications of NFB sub-
cellular distribution shown in (A). p value from
Mann-Whitney test. (C) NS2 inhibits export of
Nmd3. HeLa cells expressing Nmd3-GFP alone
(right) Nmd3-GFP and untagged NS2 (middle), or
Nmd3-GFP and untagged NS2AAAA (right). NS2 was
detected with NS2 antibodies. (D) Exogenously ex-
pressed supraNES cannot rescue the defect in viral
propagation of MVMNES22. A9 cells (n  105) were
transfected with either wild-type pdBMVp or pd-
BMV-NES22 (NES22) and cotransfected with either
GFP or GFP-NS2-NES. After 48 h the extracellular
virus pool was titered by a plaque assay using
NB324K cells. Y-axis shows the plaque forming units
(PFU). Infection with MVM-NES22 yielded micro-
plaques. Error bars, SEs from independent experi-
ments.
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transfection and titered by plaque assays using human
transformed cells (NB324K). As shown before, NES22
yielded less plaque forming units as compared with wild-
type virus (Eichwald et al., 2002). Coexpression of a su-
praNES, however, did not rescue the NS2 NES mutated
virus (Figure 3C), but instead lead to a significant decrease.
This result suggests that inhibition of the CRM1 pathway by
the supraNES is not the its main function and is consistent
with earlier reports that virus nuclear export requires intact
CRM1 function (Maroto et al., 2004).
Intranuclear Colocalization of CRM1 with Mature Virions
Is Dependent on the NS2 supraNES
Maturation of MVM coincides with the externalization of the
N-terminus of VP2 (2Nt) when capsid is filled with DNA
(Maroto et al., 2004). This viral maturation occurs in large
nuclear structures, termed Smn-associated autonomous par-
vovirus-associated replication bodies, or SAABs, which ap-
pear late in infection (Young et al., 2002b). Interestingly, NS2
has also been detected in SAABs (Young et al., 2002a,b),
suggesting a direct role in late stages of viral maturation.
Mature MVM virions can be visualized by antibodies di-
rected against the exposed 2Nt signal of VP2 (Maroto et al.,
2004), while both mature and immature virions are detected
by an anti-capsid antibody (Lopez-Bueno et al., 2004). As
shown in Supplementary Figure 3, 2Nt staining was indeed
detected primarily in SAABs. For optimal detection of
SAABs using the anti-capsid antibody, mouse cells were
briefly pre-extracted by triton permeabilization before fixa-
tion (Supplementary Figure 3). Consistent with earlier ob-
servations, NS2 is present in SAABs, colocalizing with cap-
sid (Figure 4A). This colocalization is independent of the
wild-type NS2 NES as NS2 and capsid similarly colocalize in
wild-type virus and NES22 mutant virus–expressing cells
(data not shown). CRM1, however, colocalizes with SAABs
to a far greater degree in cells expressing the wild-type
MVM genome compared with cells expressing an NES22
mutant genome (Figure 4, B and C). These data suggest an
interaction between CRM1 and the viral capsid in mouse
fibroblasts, which is mediated by the NS2 NES.
NS2 Has Supraphysiological Affinity for CRM1 and Binds
Stably without RanGTP
By definition, supraNESs should display supraphysiological
affinity for CRM1. A quantitative method to test this is the
CRM1 RanGTPase assay. This in vitro assay is based on the
inability of RanGAP to hydrolyze RanGTP when present in
transport receptor/RanGTP export complexes (Bischoff and
Gorlich, 1997; Lounsbury and Macara, 1997). RanGTP is
hydrolyzed in the absence of NES cargo, but with increasing
NES concentrations export complexes form and RanGTP is
protected from hydrolysis. High-affinity NESs will engage
more RanGTP to CRM1 and increase RanGTP protection
from hydrolysis (Kutay et al., 1997; Askjaer et al., 1999;
Paraskeva et al., 1999). As shown in Figure 5A, recombinant
NS2 bound CRM1 with  100-fold greater affinity as com-
pared with the affinity of the reference GFP-PKI-NES. As a
control for supraphysiological affinity, GFP3-S1 was used,
which possesed a similar high-affinity as NS2 (Figure 5A),
As expected, NS2AAAA did not bind CRM1.
To test RanGTP requirement of the NS2/CRM1 interac-
tion, we used surface plasmon resonance (SPR) spectroscopy
using a Biacore setup. We initially chip-immobilized CRM1
and measured surface resonance upon addition of a recom-
binant NS2 or PKI NES stream. The plasmon resonance
response is proportional to the total mass of bound mole-
cules (1000 response units  1 ng of protein). As shown in
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Figure 4. Intranuclear colocalization of CRM1 with mature viri-
ons is dependent on the NS2 supraNES. A9 cells transfected with
pdBMVp (WT) or pdBMV-NES22 (NES22) for 48 h. (A) NS2 and
capsid colocalize in SAABs. (B) CRM1 and capsid colocalize in
SAABs in a supraNES-dependent manner. Colocalization values
(R2) are displayed in the merged images. (C) Boxplots summarizing
quantification of intranuclear colocalization of CRM1 with capsid.
Pixel correlations (R) were calculated in the intranuclear region
(excluding membrane invaginations) of CRM1 with original (origi-
nal) or means of 25 randomized (random) capsid images using
ImageJ. Correlations were squared to provide a linear approxima-
tion to colocalization. p values according to Mann-Whitney test.
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Figure 5B, significant response was detected upon addition
of NS2, whereas no response was detected with the PKI NES
alone. The observed increase of signal upon addition of
recombinant RanGTP was close the calculated increase in
mass by RanGTP joining the NS2/CRM1 complex, which is
calculated as the ratio between NS2 RanGTP (58 kDa) and
NS2 alone (27 kDa). This suggests that the increased reso-
nance response can be largely attributed to RanGTP joining
the complex, without further stimulation of the NS2/CRM1
interaction per se. In contrast, RanGTP increased the re-
sponse of the PKI NES substantially above the level that can
be attributed to RanGTP alone. Termination of the NS2
stream allows one to assess the stability of the CRM1/NS2
interaction. Strikingly, both in presence or absence of
RanGTP, part of the complex is rapidly dissociated, whereas
a significant fraction of NS2 remains stably bound to CRM1.
By contrast, all CRM1/PKI/RanGTP complexes are rapidly
dissociated (Figure 5B).
CRM1 is a large suprahelical molecule that likely carries
out large-scale conformational changes upon optimal bind-
ing (Petosa et al., 2004). We therefore wondered whether the
two pools of NS2, one stably bound and one rapidly disso-
ciating, might represent pools of CRM1 differently cross-
linked on the chip. We therefore reversed the experimental
setup by chip-immobilizing NS2 and binding CRM1 in the
presence or absence of RanGTP. As shown in Figure 5C, a
significant resonance response was detected upon addition
of CRM1 alone, whereas addition of RanGTP yielded an
increase of 1.3-fold. This again can be largely attributed to
RanGTP joining the complex, because the mass ratio of
CRM1 together with RanGTP (157 kDa) and CRM1 alone
(125 kDa) equals 1.26. Interestingly, upon termination of the
CRM1 or CRM1/RanGTP stream, most of the complex de-
cayed very slowly. Plotting the two response curves to-
gether (Figure 5D) suggests that the binary complex decays
faster than the trimeric complex, indicating that the presence
of RanGTP stabilizes the CRM1/NS2 interaction, but has
little effect on the initial binding.
The NS2 supraNES Is Required for Viral Nuclear Export
Next, we wanted to evaluate the relevance of the supra-
physiological NES observed in NS2 for the viral life cycle. To
do so, we compared wild-type MVM virus to an MVM virus
carrying an NES of regular strength substituted in place of
its supraNES. In regular strength NESs such as the protein
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Figure 5. NS2 binds stably to CRM1 in a RanGTP-independent
manner. (A) Full-length NS2 protein binds CRM1 with supraphysi-
ological affinities similar to the supraNES S1. The affinity for CRM1
of NS2, NS2AAAA, the regular PKI-NES, and the supraNES S1 was
measured using the CRM1 GTPase assay. Complexes formed with
Ran[-GT32P], purified recombinant NES-bearing proteins (x-axis)
and CRM1 were subjected to RanGAP, and hydrolyzed 32P was
measured (y-axis). 100% hydrolysis was recorded when CRM1-
Ran[-GT32P] samples without cargo were subjected to RanGAP-
stimulated hydrolysis. Full-length NS2 (green) and GFP3-S1 (red)
were used as reference for supraphysiological affinity; GFP-PKI-
NES (blue) was used as control for regular affinity, and full-length
NS2AAAA protein (black) was used as negative control. (B–D) Sur-
face plasmon resonance (SPR) analysis of the NS2/CRM1 interac-
tion. (B) NS2 (green) or PKI NES (blue), alone or in combination
with RanGTP (NS2 plotted in red and PKI NES plotted in orange)
were streamed over chip-immobilized CRM1 for 40s. Resonance
response (in RU) was measured to 150 s. The dotted line denotes the
theoretical response of an NS2/RanGTP complex based on the NS2
response adjusted for the additional mass of Ran. RanGTP (black)
alone displays minor affinity for CRM1. (C) CRM1 (green) or
CRM1RanGTP (red) was streamed over chip-immobilized NS2 for
60 s. Resonance response was measured to 150 s. The dotted line
denotes the theoretical response of a CRM1/RanGTP complex
based on the CRM1 response adjusted for the additional mass of
Ran. (D) Superimposed CRM1 and CRM1RanGTP response
curves indicate a greater stability of NS2/CRM1/RanGTP (red)
over NS2/CRM1 (green).
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kinase inhibitor  (PKI) NES, mutation of one of two core
hydrophobic residues into alanine renders the NES inactive
and deficient in nuclear export (Figure 6, A and B; Wen et al.,
1994). In contrast, substitution of either of the core hydro-
phobic amino acids (L89 or I91) of the NS2 NES into alanines
converts the NS2 supraNES to a regular NES (Figure 6C).
Mutation of both hydrophobic residues is required to com-
pletely inactivate the supraNES (Figure 6C).
Interestingly, MVM NS2 NES22 harbors mutations equiv-
alent to those of the L98A mutant, namely L89Q/T90S (T90S
likely is a conservative mutation). This NES22 mutant NES
has been considered to be defective in nuclear export (Eich-
wald et al., 2002). On the basis of our NS2 point mutation
analysis, we set out to test whether the NES22 mutant is in
fact a regular strength NES. Indeed, an NS2-NES22-GFP
fusion protein was efficiently exported from the nucleus in
HeLa cells (Figure 6D). In addition, the NS2-NES22 NES
retained significant affinity toward CRM1 in vitro, albeit
substantially lower than the wild-type NS2 NES (Figure 6E).
We therefore conclude that the L89Q/T90S mutation in
NES22 decreases, but does not abolish CRM1 interaction, yet
compromises its supraphysiological capacities. Interest-
ingly, in mouse cells infected with MVM-NES22 virions, the
NS2 protein is localized mainly to the nucleus, despite its
active NES (Eichwald et al., 2002). Moreover, the MVM-
NES22 virus particles are export deficient (Eichwald et al.,
2002). To integrate these two observations, we expressed the
MVM wild-type or NES22 genome in A9 mouse fibroblasts
and monitored NS2 and viral nuclear export 42 h after
transfection. As shown in Figure 6F, wild-type virus is effi-
ciently exported from the nucleus and NS2 is predominantly
cytoplasmic. In contrast, NES22 virus fails to be exported
and NS2 is predominantly in the nucleoplasm. Because the
NS2-NES22-GFP fusion protein alone is efficiently exported,
Figure 6. The NS2 supraNES is functionally
required for viral nuclear export and infectiv-
ity. (A) Comparison of NES sequences of NS2,
PKI, and S1. Hydrophobic residues are
marked bold. The core regions of the NESs are
underlined. : L, I, F, M, or V; X: any other
residue. (B and C) MCF7 cells were transfected
with GFP-tagged NESs for 24 h. (B) Export of
the PKI-NES is inhibited upon mutation of
one hydrophobic residue. (C) A single muta-
tion in the NS2 supraNES downgrades the
supraNES to a regular NES. To inactivate the
NES activity an additional hydrophobic resi-
dues needs to be mutated. (D) NES22 behaves
like a regular NES. Cells were transfected with
GFP-NES22 and imaged using live confocal
microscopy.  LMB: cells were treated with
LMB for 10 min. (E) NES22 retains CRM1
binding activity NES. Affinity of NES22 was
tested in GAP assay as described in Figure 2A.
Synthetic peptides were used. NES22 (blue),
supraNES (green), and RevNES (red). (F)
NES22 viruses fail to be exported and the NS2-
NES22 protein is retained in the nucleoplasm.
Mouse fibroblasts expressing the WT or
NES22 genome for 42 h were stained with
anti-NS2 and anti-capsid antibodies.
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these data indicate that in the context of mature viral particle
export, the NS2-NES22 protein is retained in the nucleus by
the virus and is unable to promote virus export. Measure-
ment of viral production showed that the NS2-NES22 virus
is severely hampered in viral propagation (Eichwald et al.,
2002). We therefore conclude that the supraphysiological
properties of the NS2 NES are required for nuclear export of
the mature virus and crucial to the MVM life cycle in natural
mouse fibroblast host cells.
DISCUSSION
Supraphysiological NESs were initially identified using a
random peptide screen (Engelsma et al., 2004) and given
their cytotoxicity, it remained unclear whether this type of
NES might be encountered in nature. In this study we iden-
tify an NES with extraordinary CRM1-binding characteris-
tics in a viral protein. In retrospect, previous work on the
NS2/CRM1 interaction might already have hinted at the
unusual characteristics of the NS2/CRM1 interaction, be-
cause this interaction was readily detected in whole cell
lysates (Eichwald et al., 2002; Miller and Pintel, 2002) even in
the absence of nonhydrolyzable forms of RanGTP, which are
usually required (Fornerod et al., 1997a). The NS2 NES has
been a most useful nuclear transport research reagent (e.g.,
Daelemans et al., 2002; Petosa et al., 2004), presumably be-
cause of its robust CRM1 interaction. The robustness of the
NS2/CRM1 interaction may lay the foundation to further
address structural and biophysical aspects of CRM1/cargo
interactions.
Infectivity of the MVM virus in the host cell requires the
supraphysiological characteristics of the NS2 NES. This
raises the question why these supraphysiological character-
istics have been coopted by MVM to enhance its viral life
cycle. It is conceivable that inhibiting CRM1 provides the
virus with a cytotoxic mechanism, accelerating cell death
and thereby enhancing viral fitness. However, expression of
a supraNES did not rescue mutant NES22 infectivity (Figure
3C), consistent with the requirement for intact CRM1 func-
tion in virus nuclear export during the viral life cycle (Eich-
wald et al., 2002; Maroto et al., 2004). Also, inhibition of
CRM1 function only occurred at high NS2 expression levels
and did not correlate with Nup358 association of NS2 per se.
For these reasons it is likely that both the Nup358 interaction
and CRM1 relocalization activities of NS2 are effects of its
strong CRM1 interaction and do not necessarily imply a
primary inhibiting role. Nevertheless, inhibition of endoge-
nous NESs may disrupt trafficking of proteins involved in
the antiviral response (e.g., NFB), enhancing viral fitness
on an organismal level. Considering the interphase function
of CRM1, NS2 might act as a nuclear export factor for
mature parvovirus capsids. Indeed, nuclear egress of MVM
is inhibited upon LMB treatment (Miller and Pintel, 2002;
Maroto et al., 2004) and NS2 supraNES mutants are defective
in nuclear export of MVM viral particles. Furthermore, we
observe colocalization of CRM1, NS2, and mature virions in
nuclei of virus-infected cells (Figure 4), and NS2 can be
retained in the nucleus by mature virus (Figure 6). These
data demonstrate the requirement for the supraphysiologi-
cal properties of the NS2 NES in mediating capsid nuclear
export. We have not been able to demonstrate a direct in-
teraction between NS2 and the viral capsid and/or individ-
ual capsid proteins in vitro. It is possible, however, that the
interaction is highly regulated, complicating the in vitro
detection of the export complex. In case of other large CRM1
cargoes, notably the 60S/Nmd3/CRM1 complex, it has sim-
ilarly proven difficult to demonstrate a direct interaction.
Interestingly, Nmd3, the proposed nuclear export adaptor
for 60S preribosomal proteins, has recently been reported to
behave in a manner reminiscent of supraNESs (West et al.,
2007). A mutant of Nmd3 unable to interact with the 60S
ribosomal protein localized to the nuclear periphery in a
CRM1-dependent manner and stably interacted with
nucleoporins. The exact requirements of this interaction re-
main to be determined. Because of the similarities between
60S preribosomes and parvovirus capsids both in size and
abundance, it is tempting to speculate that these large car-
goes require an adaptor with high-affinity interactions for
CRM1 in order to be exported.
In summary, we identified a supraphysiological NES in a
viral protein that is required for viral nuclear export in
natural host cells. Our data show that in spite of their
cytotoxicity, suprahysiological NESs have evolved in nature
and are coopted to enable nuclear export of specific CRM1
cargoes like MVM viral particles. Supraphysiological export
signals may serve as a paradigm for adapting cellular trans-
port to cargo-specific needs.
ACKNOWLEDGMENTS
We thank Ursula Bodendorf (Deutsches Krebsforschungszentrum Heidel-
berg) for constructing pX-NS2P and pX-NS2-NES8, Frauke Melchior for
Nup358 antibodies, Lauran Oomen and Lenny Brocks for assistance with
confocal microscopy, Marnix Jansen, Bernike Kalverda, Stijn Heessen, and
Nikos Xylourgidis for helpful discussions and comments on the manuscript.
N.V. was in part supported by an EMBO short-term postdoctoral fellowship.
REFERENCES
Askjaer, P. et al. (1999). RanGTP-regulated interactions of CRM1 with nucleo-
porins and a shuttling DEAD-box helicase. Mol. Cell. Biol. 19, 6276–6285.
Becskei, A., and Mattaj, I. W. (2003). The strategy for coupling the RanGTP
gradient to nuclear protein export. Proc. Natl. Acad. Sci USA 100, 1717–1722.
Bernad, R., Van Der Velde, H., Fornerod, M., and Pickersgill, H. (2004).
Nup358/RanBP2 attaches to the nuclear pore complex via association with
Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated
nuclear protein export. Mol. Cell. Biol. 24, 2373–2384.
Bischoff, F. R., and Gorlich, D. (1997). RanBP1 is crucial for the release of
RanGTP from importin beta-related nuclear transport factors. FEBS Lett. 419,
249–254.
Bodendorf, U., Cziepluch, C., Jauniaux, J. C., Rommelaere, J., and Salome, N.
(1999). Nuclear export factor CRM1 interacts with nonstructural proteins NS2
from parvovirus minute virus of mice. J. Virol. 73, 7769–7779.
Daelemans, D., Afonina, E., Nilsson, J., Werner, G., Kjems, J., De Clercq, E.,
Pavlakis, G. N., and Vandamme, A. M. (2002). A synthetic HIV-1 Rev inhibitor
interfering with the CRM1-mediated nuclear export. Proc. Natl. Acad. Sci.
USA 99, 14440–14445.
Eichwald, V., Daeffler, L., Klein, M., Rommelaere, J., and Salome, N. (2002).
The NS2 proteins of parvovirus minute virus of mice are required for efficient
nuclear egress of progeny virions in mouse cells. J. Virol. 76, 10307–10319.
Engelsma, D., Bernad, R., Calafat, J., and Fornerod, M. (2004). Supraphysi-
ological nuclear export signals bind CRM1 independently of RanGTP and
arrest at Nup358. EMBO J. 23, 3643–3652.
Faisst, S., Faisst, S. R., Dupressoir, T., Plaza, S., Pijol, A., Jauniaux, J. C., Rhode,
S. L., and Rommelaere, J. (1995). Isolation of a fully infectious variant of
parvovirus H-1 supplanting the standard strain in human cells. J. Virol. 69,
4538–4543.
Fontoura, B. M., Faria, P. A., Nussenzveig, D. R. (2005). Viral interactions with
the nuclear transport machinery: discovering and disrupting pathways.
IUBMB Life 57, 65–72.
Fornerod, M., and Ohno, M. (2002). Exportin-mediated nuclear export of
proteins and ribonucleoproteins. Results Probl. Cell Differ. 35, 67–91.
Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I. W. (1997a). CRM1 is an
export receptor for leucine-rich nuclear export signals. Cell 90, 1051–1060.
Fornerod, M., van-Deursen, J., van-Baal, S., Reynolds, A., Davis, D., Murti,
K. G., Fransen, J., and Grosveld, G. (1997b). The human homologue of yeast
CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear
pore component Nup88. EMBO J. 16, 807–816.
A Viral Supraphysiological NES
Vol. 19, June 2008 2551
Henderson, B. R., and Eleftheriou, A. (2000). A comparison of the activity,
sequence specificity, and CRM1-dependence of different nuclear export sig-
nals. Exp. Cell Res. 256, 213–224.
Ho, J. H., Kallstrom, G., and Johnson, A. W. (2000). Nmd3p is a Crm1p-
dependent adapter protein for nuclear export of the large ribosomal subunit.
J. Cell Biol. 151, 1057–1066.
Kutay, U., Bischoff, F. R., Kostka, S., Kraft, R., and Gorlich, D. (1997). Export
of importin alpha from the nucleus is mediated by a specific nuclear transport
factor. Cell 90, 1061–1071.
Lopez-Bueno, A., Mateu, M. G., and Almendral, J. M. (2003). High mutant
frequency in populations of a DNA virus allows evasion from antibody
therapy in an immunodeficient host. J. Virol. 77, 2701–2708.
Lopez-Bueno, A., Valle, N., Gallego, J. M., Perez, J., and Almendral, J. M.
(2004). Enhanced cytoplasmic sequestration of the nuclear export receptor
CRM1 by NS2 mutations developed in the host regulates parvovirus fitness.
J. Virol. 78, 10674–10684.
Lounsbury, K. M., and Macara, I. G. (1997). Ran-binding protein 1 (RanBP1).
forms a ternary complex with Ran and karyopherin beta and reduces Ran
GTPase-activating protein (RanGAP). inhibition by karyopherin beta. J. Biol.
Chem. 272, 551–555.
Maroto, B., Valle, N., Saffrich, R., and Almendral, J. M. (2004). Nuclear export
of the nonenveloped parvovirus virion is directed by an unordered protein
signal exposed on the capsid surface. J. Virol. 78, 10685–10694.
Miller, C. L., and Pintel, D. J. (2002). Interaction between parvovirus NS2
protein and nuclear export factor Crm1 is important for viral egress from the
nucleus of murine cells. J. Virol. 76, 3257–3266.
Nachury, M. V., and Weis, K. (1999). The direction of transport through the
nuclear pore can be inverted. Proc. Natl. Acad. Sci. USA 96, 9622–9627.
Ohshima, T., Nakajima, T., Oishi, T., Imamoto, N., Yoneda, Y., Fukamizu, A.,
and Yagami, K. (1999). CRM1 mediates nuclear export of nonstructural pro-
tein 2 from parvovirus minute virus of mice. Biochem. Biophys. Res. Com-
mun. 264, 144–150.
Pante, N., and Kann, M. (2002). Nuclear pore complex is able to transport
macromolecules with diameters of about 39 nm. Mol. Biol. Cell 13, 425–434.
Paraskeva, E., Izaurralde, E., Bischoff, F. R., Huber, J., Kutay, U., Hartmann,
E., Lu¨hrmann, R., and Go¨rlich, D. (1999). CRM1-mediated recycling of snur-
portin 1 to the cytoplasm. J. Cell Biol. 145, 255–264.
Petosa, C., Schoehn, G., Askjaer, P., Bauer, U., Moulin, M., Steuerwald, U.,
Soler-Lopez, M., Baudin, F., Mattaj, I. W., and Muller, C. W. (2004). Architec-
ture of CRM1/Exportin1 suggests how cooperativity is achieved during
formation of a nuclear export complex. Mol. Cell 16, 761–775.
Roth, P., Xylourgidis, N., Sabri, N., Uv, A., Fornerod, M., and Samakovlis, C.
(2003). The Drosophila nucleoporin DNup88 localizes DNup214 and CRM1
on the nuclear envelope and attenuates NES-mediated nuclear export. J. Cell
Biol. 163, 701–706.
Tam, W. F., Lee, L. H., Davis, L., and Sen, R. (2000). Cytoplasmic sequestration
of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export [In
Process Citation]. Mol. Cell. Biol. 20, 2269–2284.
Thomas, F., and Kutay, U. (2003). Biogenesis and nuclear export of ribosomal
subunits in higher eukaryotes depend on the CRM1 export pathway. J. Cell
Sci. 116, 2409–2419.
Walther, T. C., Pickersgill, H. S., Cordes, V. C., Goldberg, M. W., Allen, T. D.,
Mattaj, I. W., and Fornerod, M. (2002). The cytoplasmic filaments of the
nuclear pore complex are dispensable for selective nuclear protein import.
J. Cell Biol. 158, 63–77.
Wen, W., Harootunian, A. T., Adams, S. R., Feramisco, J., Tsien, R. Y.,
Meinkoth, J. L., and Taylor, S. S. (1994). Heat-stable inhibitors of cAMP-
dependent protein kinase carry a nuclear export signal. J. Biol. Chem. 269,
32214–32220.
West, M., Hedges, J. B., Lo, K. Y., and Johnson, A. W. (2007). Novel interaction
of the 60S ribosomal subunit export adapter Nmd3 at the nuclear pore
complex. J. Biol. Chem., 282, 14028–14037.
Young, P. J., Jensen, K. T., Burger, L. R., Pintel, D. J., and Lorson, C. L. (2002a).
Minute virus of mice NS1 interacts with the SMN protein, and they colocalize
in novel nuclear bodies induced by parvovirus infection. J. Virol. 76, 3892–
3904.
Young, P. J., Jensen, K. T., Burger, L. R., Pintel, D. J., and Lorson, C. L. (2002b).
Minute virus of mice small nonstructural protein NS2 interacts and colocal-
izes with the Smn protein. J. Virol. 76, 6364–6369.
D. Engelsma et al.
Molecular Biology of the Cell2552
